Prescription Monitoring Program; requirements of prescribers, exceptions. (HB333)
Introduced By
Del. David Yancey (R-Newport News)
Progress
✓ |
Introduced |
✗ |
Passed Committee |
☐ |
Passed House |
☐ |
Passed Senate |
☐ |
Signed by Governor |
☐ |
Became Law |
Description
Prescription Monitoring Program; requirements of prescribers; exceptions. Provides that a prescriber initiating a new course of treatment to a human patient that includes the prescribing of opioids, anticipated at the onset of treatment to last more than seven consecutive days, shall not be required to request information about the patient from the Prescription Monitoring Program if the purpose of the prescription is the management of pain associated with cancer. Read the Bill »
Outcome
Bill Has Failed
History
Date | Action |
---|---|
01/04/2018 | Committee |
01/04/2018 | Prefiled and ordered printed; offered 01/10/18 18103337D |
01/04/2018 | Referred to Committee on Health, Welfare and Institutions |
01/15/2018 | Assigned HWI sub: |
01/15/2018 | Assigned HWI sub: Subcommittee #2 |
01/23/2018 | Subcommittee recommends passing by indefinitely (10-Y 0-N) |
01/25/2018 | Impact statement from VDH (HB333) |
02/13/2018 | Left in Health, Welfare and Institutions |